×
GETINGE Receivables 2016-2024 | GNGBY
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
GETINGE receivables from 2016 to 2024. Receivables can be defined as the total amount of collectibles for a company
View More
GETINGE Receivables 2016-2024 | GNGBY
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
GETINGE receivables from 2016 to 2024. Receivables can be defined as the total amount of collectibles for a company
Related Stocks
Company Name
Market
Cap
Danaher (DHR)
$160.9B
Elevance Health (ELV)
$91.8B
Cencora (COR)
$49.1B
Natera (NTRA)
$23.4B
DiDi Global (DIDIY)
$22.6B
ICON (ICLR)
$16.4B
Revvity (RVTY)
$15.4B
Avantor (AVTR)
$15.2B
BioMerieux (BMXMF)
$14.4B
Viatris (VTRS)
$13.5B
CochLear (CHEOY)
$13B
Solventum (SOLV)
$12.8B
Doximity (DOCS)
$11B
Medpace Holdings (MEDP)
$10.9B
EUROFINS SCIENT (ERFSF)
$10.4B
HealthEquity (HQY)
$9.6B
Charles River Laboratories (CRL)
$8.4B
Sonic Healthcare (SKHHY)
$8.3B
Amplifon S.p.A (AMFPF)
$6.1B
Bausch + Lomb (BLCO)
$6.1B
BrightSpring Health Services (BTSG)
$4.1B
Organon (OGN)
$4B
Sotera Health (SHC)
$3.9B
Surgery Partners (SGRY)
$3.2B
Concentras Parent (CON)
$3B
Alignment Healthcare (ALHC)
$3B
PACS (PACS)
$2.2B
Premier (PINC)
$2.2B
Ardent Health Partners (ARDT)
$2.1B
GeneDx Holdings (WGS)
$2.1B